The US National Library of Medicine defines evidence-based medicine as “the process of systematically finding, appraising, and using contemporaneous research findings as the basis of clinical decisions. Evidence-based medicine asks questions, finds and appraises relevant data, and harnesses that information for everyday clinical practice.”

On this basis, Evidence-Based Diabetes Management^™ (EBDM^™) seeks high-quality commentaries and original research reports on cutting-edge clinical, pharmacoeconomic, and regulatory topics in diabetes care. The objective is to provide patients, clinicians, payers, health plans, and the pharmaceutical community, evidence-based information to aid care decisions. The editors are especially interested in papers that promote dialogue and facilitate communication among stakeholders and healthcare policy makers that would potentially impact the efficiency and outcomes in diabetes care. EBDM^™ regularly publishes articles that cover:

• Medication adherence
• Drug pipelines
• Devices and personal technology
• Behavioral interventions for weight loss
• Scalable diagnostic techniques/biomarkers
• Health policy (private, Medicare, and Medicaid)
• Quality of care / issues related to measurement
• Patient engagement, including social media

We would like to highlight that EBDM^™ would be an ideal platform to publish findings which may not be extensive enough to support a complete article for publication in a peer-reviewed journal and demand timely appearance to achieve an impact.

EBDM™ makes its content available online at no cost and does not require a subscription, thus expanding the reach of the published data. The contributing authors are not required to cover publication costs. We are an indexed publication but we do not undergo a rigorous peer-review process. 

If you wish to submit to EBDM™, or have further questions, please contact Managing Editor Mary K. Caffrey, mcaffrey@ajmc.com.